Related references
Note: Only part of the references are listed.EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV
Lucie Poppova et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
PI3K/AKT/mTOR-Dependent Stabilization of Oncogenic Far-Upstream Element Binding Proteins in Hepatocellular Carcinoma Cells
Jana Samarin et al.
HEPATOLOGY (2016)
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis
Tarek M. A. Abdel-Fatah et al.
LANCET ONCOLOGY (2016)
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Cora N. Sternberg et al.
LANCET ONCOLOGY (2015)
Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway
M. K. Siu et al.
ONCOGENE (2015)
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway
P-P Liu et al.
CELL DEATH AND DIFFERENTIATION (2014)
Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells
Yuan Peng et al.
CELLULAR SIGNALLING (2014)
Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
Jeffrey J. Leow et al.
EUROPEAN UROLOGY (2014)
Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling
Stephanie Cornen et al.
PLOS ONE (2014)
Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells
Kathrin Thedieck et al.
CELL (2013)
Prospective Evaluation of a Molecular Marker Panel for Prediction of Recurrence and Cancer-specific Survival After Radical Cystectomy
Yair Lotan et al.
EUROPEAN UROLOGY (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
Brian M. Slomovitz et al.
CLINICAL CANCER RESEARCH (2012)
CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity
Amity L. Manning et al.
EMBO JOURNAL (2010)
Personalized Medicine: Marking a New Epoch in Cancer Patient Management
Maria Diamandis et al.
MOLECULAR CANCER RESEARCH (2010)
Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation
Chan Gao et al.
NATURE CELL BIOLOGY (2010)
Gene Expression Profiles of Non-Small Cell Lung Cancer: Survival Prediction and New Biomarkers
Kristjan Vaelk et al.
ONCOLOGY (2010)
Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer
Steven Buechler
BMC CANCER (2009)
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
A. Bengochea et al.
BRITISH JOURNAL OF CANCER (2008)
Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells
Miran Kim et al.
JOURNAL OF HEPATOLOGY (2008)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation
Sung-Eun Kim et al.
CELLULAR SIGNALLING (2007)
Differential susceptibility to TRAIL of normal versus malignant human urothelial cells
L. P. Steele et al.
CELL DEATH AND DIFFERENTIATION (2006)
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy
Y Lotan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Analysis of mitotic microtubule-associated proteins using mass spectrometry identifies astrin, a spindle-associated protein
GJ Mack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cloning and characterization of hMAP126, a new member of mitotic spindle-associated proteins
MS Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
JP Stein et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
